CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 35 enrolled
Drug / intervention
Varithena® +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02462720
NCT02462720Phase 4Completed
CompareCT.gov

Multicenter Study to Evaluate Pain Following Treatment of Varicose Vein With Varithena® Compared to Radiofrequency Ablation

Boston Scientific Corporation·interventional·Posted Jun 4, 2015·Updated Apr 21, 2021

In Brief

A Phase 4 clinical trial evaluating Varithena® and Radiofrequency ablation for Varicose Veins. Completed, enrolled 35 participants across 4 sites.

Detailed Summary

The purpose of this study is to evaluate pain the patient experienced following treatment of varicose veins with Varithena® compared to radiofrequency ablation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVaricose Veins
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 4, 2015
Enrollment StartMay 1, 2015
Primary CompletionDec 1, 2015
Study CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.1 years ago

Interventions

Varithena®drug

Varithena® treatment in accordance with full prescribing information and instructions for use

Radiofrequency ablationdevice

Radiofrequency ablation conducted per physicians' standard of care.